Cost-effectiveness of SelectMDx for prostate cancer in four European countries : a comparative modeling study
T. Govers, D. Hessels, V. Vlaeminck-Guillem, B. Schmitz-Draeger, C. Stief, C. Martinez-Ballesteros, M. Ferro, A. Borque-Fernando, J. Rubio-Briones, J. Sedelaarll, W. Van Criekinge and J. Schalken
(2019) PROSTATE CANCER AND PROSTATIC DISEASES,
22,